Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
lundi, octobre 19
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
VivoPower PLC
VIVO
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$2.14
0.04
1.9%
Dern. MÀJ: Oct 16, 7:57 PM
$2.14
0.04
1.9%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
VivoPower Financials
VivoPower (VIVO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Meridian Bioscience's Return On Capital Employed Overview
Benzinga Insights
PRO
Meridian Bioscience Q4 EPS $0.20 Down From $0.23 YoY, Sales $65.67M Down From $76.20M YoY
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.20 per share. This is a 13.04 percent decrease over earnings of $0.23 per share from the same period last year. The company reported $65.67 million in
Benzinga Newsdesk
Looking Into Meridian Bioscience's Return On Capital Employed
Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 125.52%, resulting in a loss of $7.34 million.
Benzinga Insights
Meridian Bioscience: Q3 Earnings Insights
Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga Insights
PRO
Meridian Bioscience Q3 EPS $0.16, Inline, Sales $67.80M Beat $66.82M Estimate
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 27.27 percent decrease over earnings of $0.22 per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Benzinga Insights
